Eclipsebio
PrivateLast Round
Grant
Jul 1, 2024
Total Funding Raised
$17.88M
Momentum Score
25 /100
Company Overview
Eclipsebio is a biotechnology company that develops first-in-class technologies, analyses, and platforms for the development of RNA-based and RNA-targeting therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Hardware Sales
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eclipsebio Comps
Public and private peers based on sector, stage, and business model.
Eclipsebio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 1, 2024 | ||||
| Series A | Mar 15, 2022 | ||||
| Seed | Jun 5, 2020 | ||||
| Grant | Sep 17, 2019 | ||||
| Grant | Sep 20, 2017 |
Eclipsebio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Phoenix Venture Partners | Series A |
| Alexandria Venture Investments | Series A |
| National Institute of General Medical Sciences | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
Launched eCOMPASS platform for AI-driven RNA therapeutic development.
- Jan 26, 2026
Acquired Terrain Biosciences to advance RNA therapeutic design.
Eclipsebio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Eclipsebio's valuation, stock price, and market status.
